Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125363151 | 12536315 | 1 | I | 2013 | 20160628 | 20160707 | 20160707 | EXP | US-PFIZER INC-2016322794 | PFIZER | 73.00 | YR | M | Y | 108.00000 | KG | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125363151 | 12536315 | 1 | PS | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 5 MG, DAILY | 17783 | 5 | MG | ||||||||
| 125363151 | 12536315 | 2 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
| 125363151 | 12536315 | 3 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 6.25 MG, 2X/DAY | 0 | 6.25 | MG | TABLET | BID | ||||||
| 125363151 | 12536315 | 4 | C | WARFARIN | WARFARIN | 1 | Oral | UNK (3MG SUNDAY, MONDAY, WEDNESDAY AND FRIDAY AND 6 MG TUESDAY, THURSDAY AND SATURDAY) | 0 | TABLET | |||||||||
| 125363151 | 12536315 | 5 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | Oral | 7.5 MG, 2X/DAY | 0 | 7.5 | MG | TABLET | BID | ||||||
| 125363151 | 12536315 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, 3X/DAY (TWO TABLETS IN THE MORNING AND ONE TABLET IN THE EVENING) | 0 | 40 | MG | TABLET | TID | ||||||
| 125363151 | 12536315 | 7 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD | ||||||
| 125363151 | 12536315 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 75 MG, DAILY | 0 | 75 | MG | TABLET | |||||||
| 125363151 | 12536315 | 9 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125363151 | 12536315 | 1 | Diabetes mellitus |
| 125363151 | 12536315 | 2 | Gout |
| 125363151 | 12536315 | 3 | Cardiac disorder |
| 125363151 | 12536315 | 4 | Antiplatelet therapy |
| 125363151 | 12536315 | 5 | Anxiety |
| 125363151 | 12536315 | 6 | Fluid imbalance |
| 125363151 | 12536315 | 7 | Blood pressure measurement |
| 125363151 | 12536315 | 8 | Thyroid disorder |
| 125363151 | 12536315 | 9 | Blood cholesterol |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125363151 | 12536315 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125363151 | 12536315 | Confusional state | |
| 125363151 | 12536315 | Dizziness | |
| 125363151 | 12536315 | Fall | |
| 125363151 | 12536315 | Gait disturbance | |
| 125363151 | 12536315 | Headache | |
| 125363151 | 12536315 | Hunger | |
| 125363151 | 12536315 | Impaired driving ability | |
| 125363151 | 12536315 | Loss of consciousness | |
| 125363151 | 12536315 | Nausea | |
| 125363151 | 12536315 | Vertigo | |
| 125363151 | 12536315 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125363151 | 12536315 | 1 | 20121218 | 0 | ||
| 125363151 | 12536315 | 2 | 1983 | 0 |